The Journal of the National Cancer Institute(JNCI) features a two-page piece on the IARC decision in its August 3 issue. Many of the usual cast of characters (Feychting, Hardell, Moskowitz, Samet, Swerdlow, Tarone) are quoted except, surprisingly, anyone from NCI. Not a word from either Peter Inskip or Martha Linet (see June 29).
And there is this in the third paragraph of the story: "The [NCI], the American Cancer Society and other organizations were at pains to update their online information and reassure worried consumers that the [IARC] action was not based on any clinically meaningful new evidence but merely on an evaluation of the existing literature. Experts repeated the familiar mantra 'more research is needed,' even as newspaper headlines warned of the potential risk."
Is it really the NCI's job to pacify the public about uncertain risks?